TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 52 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,562,254 | +378.1% | 810,840 | 0.0% | 0.00% | – |
| Q2 2023 | $535,965 | -17.1% | 810,840 | 0.0% | 0.00% | – |
| Q1 2023 | $646,726 | -64.7% | 810,840 | -0.0% | 0.00% | -100.0% |
| Q4 2022 | $1,833,016 | +17.1% | 811,069 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,565,000 | -48.1% | 811,069 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,017,000 | -64.4% | 811,069 | -37.6% | 0.00% | -66.7% |
| Q1 2022 | $8,480,000 | -44.4% | 1,300,668 | -0.6% | 0.00% | -40.0% |
| Q4 2021 | $15,244,000 | -37.5% | 1,308,533 | -0.1% | 0.01% | -44.4% |
| Q3 2021 | $24,396,000 | -11.9% | 1,310,210 | +0.3% | 0.01% | -18.2% |
| Q2 2021 | $27,684,000 | +21.9% | 1,305,846 | +16.7% | 0.01% | +22.2% |
| Q1 2021 | $22,719,000 | +7.1% | 1,119,169 | +40.0% | 0.01% | 0.0% |
| Q4 2020 | $21,220,000 | +18.3% | 799,529 | -0.1% | 0.01% | 0.0% |
| Q3 2020 | $17,932,000 | – | 800,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |